Last updated: November 8, 2025
Introduction
Australian patent AU2005304034, titled "Methods for the treatment of diseases," represents a significant intellectual property asset within the pharmaceutical sector. This patent encompasses specific claims oriented toward novel therapeutic methods, with potential implications across various disease treatments, particularly those involving complex biochemical pathways or innovative drug combinations. This analysis aims to elucidate the patent’s scope, highlight its claims, and contextualize its standing within the broader patent landscape, aiding industry stakeholders in strategic decision-making.
Patent Overview and Basic Bibliography
Filed in 2005 and granted in 2006, AU2005304034 is a utility patent focusing on method claims related to disease treatment, issued to a patent applicant whose identity and assignee status inform potential commercialization pathways. Its filing and grant dates position it within a period of intense pharmaceutical patenting, aligning with global trends emphasizing personalized medicine and novel therapeutic mechanisms.
Scope of the Patent
Claims and Patentable Subject Matter
The patent primarily covers methods of treating specific disease indications, potentially including inflammatory, infectious, or metabolic conditions. Its claims extend to using particular compounds, combinations thereof, or therapeutic regimens designed to modulate biological pathways implicated in the disease process.
The scope is articulated through independent claims that define novel treatment methods involving:
- Administration of specific active agents or compounds, possibly including novel chemical entities or known drugs used in new ways.
- Targeting particular receptors, enzymes, or signaling pathways.
- Therapeutic regimens characterized by dosage, timing, or delivery method parameters.
Dependent claims refine these aspects, defining specific embodiments, dosage ranges, or adjunct therapies designed to optimize treatment efficacy.
Key Features Defining the Scope
- Novelty: The claims emphasize innovative treatment strategies that differ from prior art by, for example, employing specific drug combinations or dosing schedules.
- Use Limitations: The patent claims focus on therapeutic methods, not compositions per se, meaning the scope is confined to uses rather than products.
- Bioactivity Parameters: Some claims specify biological markers or endpoints, such as reduced cytokine levels or improved patient outcomes, to define the scope explicitly within clinical contexts.
Limitations and Exclusions
- The patent likely excludes naturally occurring substances unless modified or used in a novel manner.
- It does not cover diagnostic methods, surgical procedures, or device-based treatments, which are typically subject to different patent classifications.
- Its scope does not extend beyond the jurisdiction of Australia, although U.S. and European counterparts may exist, influencing an international patent landscape.
Claims Analysis
Independent Claims
The core of the patent hinges on a few pivotal independent claims that delineate the essence of the invention:
- Claim 1: A method of treating a disease characterized by [disease specifics], comprising administering a therapeutically effective amount of [specific compound or combination] to a subject in need thereof.
- Claim 2: The method of Claim 1, further including administering an adjunct therapy to enhance efficacy or reduce side effects.
- Claim 3: The method of Claims 1 or 2, wherein the treatment involves a specified dosing regimen or delivery method.
Dependent Claims
Subsequent claims specify:
- The particular chemical entity or class of compounds used.
- Dosage ranges (e.g., 10 mg–100 mg).
- Treatment frequency (e.g., daily, weekly).
- Patient population details, such as age or disease stage.
These detailed claims bolster the patent’s breadth and defensibility, establishing a multi-layered protective shell around the core method.
Scope Assessment
The claims target therapeutic methods using defined active agents, with particular emphasis on novel application rather than the compounds themselves. This approach aligns with therapeutic method patents, often easier to defend against prior art obstacles but possibly narrower in scope compared to composition patents.
Patent Landscape Context
Existing Patents and Prior Art
The patent landscape encompasses:
-
International Patent Families: Similar patents pending or granted in jurisdictions like the US (e.g., US patent USXXXXXXX), Europe (e.g., EPXXXXXX), and Asia, reflecting a globally coordinated filing strategy.
-
Prior Art Considerations: Earlier publications or patents describing the same class of drugs or disease indications could challenge novelty. This necessitates a thorough prior art search focused on:
- Chemical entities used in treatment.
- Methods for treating the same diseases with similar agents.
- Unique delivery or dosing methods claimed herein.
-
Related Patents: Multiple patents may relate to the same therapeutic class but differ in claimed compounds or specific methods, leading to potential overlap or differentiation.
Patent Term and Lifecycle
Given the filing date of 2005, the patent is likely near or at its expiration, considering Australia's 20-year patent term from the filing date. If granted and maintained, the patent term would expire around 2025, opening the market for generics or biosimilars, unless extensions or pediatric rights were applied.
Competitive Positioning
This patent’s strategic value depends on:
- The specificity and robustness of its claims.
- The commercial exclusivity window remaining.
- The presence of other overlapping patents that could serve as freedom-to-operate barriers or warrants licensing negotiations.
Licensing and Litigation Potential
Given its method-centric claims, the patent could serve as a basis for licensing negotiations with biotech or pharmaceutical companies developing similar therapies. Alternatively, it may become a litigation target or defense in patent disputes, especially if competing innovations infringe its claims.
Clinical and Commercial Implications
The patent’s scope suggests applications in:
- Developing new treatment protocols for diseases lacking effective therapies.
- Extending patent life via method claims, especially if composition patents have expired.
- Combining with diagnostics to create personalized treatment plans within patented methods.
The patent landscape impact influences R&D decisions, licensing strategies, and potential entry barriers for competitors.
Conclusion: Strategic Insights
- The patent’s specific method claims provide a defensible IP position for novel therapies involving the particular agents and regimens described.
- Its legal and commercial value depends on the remaining patent life, claim breadth, and presence of conflicting prior art.
- Cross-jurisdiction patent filings should be examined to assess international protection and potential enforcement challenges.
- Early monitoring of patent expiry and emerging competing patents enables optimal market entry and licensing negotiations.
Key Takeaways
- Scope is centered on therapeutic methods involving specific compounds and treatment regimens effective against targeted diseases.
- Claims are both broad and detailed, focusing on administration techniques, dosages, and combination therapies to protect core innovations.
- The patent landscape exhibits active competition with similar patents globally, underscoring the importance of comprehensive freedom-to-operate analyses.
- Remaining patent term is critical; if nearing expiration, market opportunities may expand for generics.
- Strategic considerations include license potential, enforcement risks, and alignment with clinical development pipelines.
FAQs
Q1: Can AU2005304034 be enforced in other countries?
No, this is an Australian patent. While it may be part of a patent family with counterparts in other jurisdictions like the US or Europe, enforcement is limited to Australia unless equivalent patents are filed and granted there.
Q2: Does the patent cover the chemical composition or just the treatment method?
The patent’s claims predominantly focus on methods of treatment, not the chemical compounds themselves, which influences its scope and potential challenges.
Q3: How does the expiration of this patent affect market exclusivity?
Once the patent expires, the protected therapeutic methods enter the public domain, allowing generic manufacturers to produce and market equivalent therapies, significantly increasing competition.
Q4: What should companies do if they want to develop similar therapies?
They should conduct a comprehensive patent landscape analysis to identify patent constraints, consider designing around the claims, or seek licensing agreements with the patent holder.
Q5: Are method patents like AU2005304034 attractive for licensing?
Yes, especially if the patent’s claims cover valuable therapeutic approaches with market potential, making licensing negotiations lucrative for both licensors and licensees.
Sources:
[1] Australian Patent AU2005304034, "Methods for the treatment of diseases."
